Lilly (LLY) Tops Q2 EPS by 20c

Go back to Lilly (LLY) Tops Q2 EPS by 20c

Lilly (LLY) to Separate Elanco Animal Health with IPO

July 24, 2018 6:21 AM EDT

Eli Lilly and Company (NYSE: LLY) today announced that the company has completed its strategic review of Elanco Animal Health, and will file a registration statement in the coming weeks with the U.S. Securities and Exchange Commission (SEC) for a potential initial public offering (IPO) of a minority ownership stake in Elanco as a separate company.

The offering is expected to... More